Sharda Cropchem Limited (SHARDACROP)

Loading page…

Sharda Cropchem Limited (SHARDACROP) · mywealthgrid

About

Sharda Cropchem Limited manufactures pesticides and agrochemicals for Indian agriculture, with a market capitalisation of ₹7,093 Cr. Quarterly revenues range from ₹800 Cr to ₹2,100 Cr, with operating margins averaging 20.43%, placing it in the mid-profitability band within its sector. The company serves the domestic fertilizers and agrochemicals industry, which is cyclical and dependent on monsoon patterns and government agricultural policy.

Face value: ₹10

Market cap

₹6,397 Cr

P/E

10.2×

P/B

2.0×

Dividend yield

2.1%

ROE

24.2%

ROCE

28%

Debt / equity

OPM

20.4%

EPS (TTM)

₹69.4

Book value

₹347.6

52-week high

—

52-week low

Key insights

Company research notes and source-linked reviews

Key risks

Operating margin volatility from 10.37% (Sep 2025) to 23.76% (Mar 2026) signals unpredictable profitability
Stock price down 20.92% over 1 year, trading near 52w low (₹786 vs ₹1,256 peak); PE of 11.33 may reflect market concern
EPS volatility from ₹4.88 to ₹39.06 in recent quarters indicates earnings unpredictability; FII holdings fell from 4.6% to 3.11% between Mar and Jun 2026
Agricultural sector dependency on monsoon adequacy and commodity cycles; verify revenue predictability and customer diversification

Generated analysis · source review pending

Growth drivers

Margin recovery from Sep 2025 lows (10–14% OPM) to Jun 2026 (17–18% OPM) indicates operational turnaround underway
Mar quarter seasonality: consistent 23%+ margins suggest structural demand strength; verify drivers and sustainability
ROE of 24.16% demonstrates capital efficiency and capacity to reinvest earnings or return cash to shareholders
Zero debt (D/E 0) provides financial flexibility for expansion or acquisitions without new leverage

Generated analysis · source review pending

2,528 historical price candles were omitted because the exchange source has not been verified.

₹709.2-1.7%1Y

Quick read

rule-based

Pros

+Healthy operating margin of 20.4%
+Profit CAGR of 24.3% over the last 5 years
+Revenue CAGR of 17.1% over the last 5 years
+Almost debt-free (debt/equity 0)
+Comfortable interest coverage of 487.1×
+High promoter holding of 74.8% with no pledge

Cons

No red flags triggered.

Research score

Structured signal from quality, growth, valuation and momentum.

73/100

Business quality: 81
Growth: 42
Valuation

Revenue & net profit

₹ crore, by fiscal year

RevenuePAT

Margins

% of revenue, by fiscal year

OPMPAT margin

Peers

Comparable companies from the narrowest available industry classification.

Part ofNIFTY MICROCAP 250 NIFTY TOTAL MARKET

Screen this industry Compare top 5 side-by-side

Company	Mkt Cap	EV	Revenue	EBITDA	OPM	PAT	NPM	ROCE	ROE	WC Days
Upl LimitedUPLUPL	₹43,628 Cr	₹65,674 Cr	₹52,804 Cr	₹9,326 Cr	17.9%	₹2,020 Cr	4.3%	11.2%	6%	135
Sumitomo Chemical India LimitedSUMICHEMSUMICHEM	₹20,842 Cr	₹20,844 Cr	₹3,245 Cr	₹685 Cr	20.7%	₹579 Cr	16.8%	23.1%	17.3%	155
Bayer Cropscience LimitedBAYERCROPBAYERCROP	₹15,958 Cr	—	₹5,472 Cr	₹688 Cr	15.4%	₹568 Cr	12.1%	28.4%	23.7%	300
Sharda Cropchem LimitedSHARDACROPSHARDACROP	₹6,397 Cr	₹6,397 Cr	₹5,357 Cr	₹1,047 Cr	20.4%	₹626 Cr	12.9%	28%	24.2%	125
Dhanuka Agritech LimitedDHANUKADHANUKA	₹4,217 Cr	₹4,259 Cr	₹2,035 Cr	₹417 Cr	20.5%	₹297 Cr	14.6%	28.9%	22.3%	160
Rallis India LimitedRALLISRALLIS	₹3,884 Cr	₹3,942 Cr	₹2,604 Cr	₹274 Cr	10.5%	₹164 Cr	6.3%	13.2%	10%	104
Bhagiradha Chemicals & Industries LimitedBHAGCHEMBHAGCHEM	₹3,063 Cr	₹3,294 Cr	₹607 Cr	₹79 Cr	10.7%	₹28 Cr	3.4%	4.8%	2.6%	148
Nacl Industries LimitedNACLINDNACLIND	₹3,054 Cr	₹3,355 Cr	₹1,519 Cr	₹106 Cr	6.5%	₹12 Cr	0.3%	11.8%	0.8%	105
Gsp Crop Science LimitedGSPCROPGSPCROP	₹2,113 Cr	₹2,373 Cr	₹1,517 Cr	₹185 Cr	12.2%	₹-3 Cr	6.2%	20.7%	-0.4%	121
Bharat Rasayan LimitedBHARATRASBHARATRAS	₹1,658 Cr	₹1,659 Cr	₹1,203 Cr	₹177 Cr	16%	₹140 Cr	11.7%	17.5%	12.1%	219
Insecticides (India) LimitedINSECTICIDINSECTICID	₹1,655 Cr	₹1,799 Cr	₹2,060 Cr	₹210 Cr	10.6%	₹125 Cr	6.5%	17.1%	12.1%	168
Astec Lifesciences LimitedASTECASTEC	₹1,580 Cr	₹2,029 Cr	₹441 Cr	₹6 Cr	-1%	₹-67 Cr	-18.1%	-9.3%	-25.9%	263

Loading peers…

Financials

Reported profit and loss, balance sheet, cash flow and growth history.

Annual Quarterly

Consolidated Standalone

Consolidated figures · ₹ crore

₹ Cr	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	1,222	1,399	1,707	1,998	2,003	2,396	3,580	4,045	3,163	4,320	5,268
COGS	290	423	441	—	1,389	1,636	2,500	2,861	2,342	3,028	3,377
Gross profit	932	976	1,265	—	614	760	1,080	1,184	821	1,292	1,890
	661	664	912	—	332	323	397	541	538	696	814
	271	312	354	—	282	437	683	643	283	596	1,076
OPM %	22.2%	22.3%	20.7%	—	14.1%	18.2%	19.1%	15.9%	8.9%	13.8%	20.4%
Depreciation	35	56	70	343	137	170	245	248	267	275	325
Interest	1	0	5	8	2	3	2	5	4	2	2
	25	16	8	21	42	46	29	40	60	60	106
Profit before tax	261	272	287	—	185	309	464	431	72	378	856
Tax	86	81	96	59	20	80	115	89	40	74	175
Tax %	33%	30%	33.6%	—	10.9%	25.9%	24.8%	20.6%	55.6%	19.5%	20.4%
	175	190	191	176	165	229	349	342	32	304	681
PAT margin %	14.3%	13.6%	11.2%	8.8%	8.2%	9.6%	9.8%	8.5%	1%	7.1%	12.9%
EPS (₹)	—	—	—	—	18.3	25.4	38.7	37.9	3.5	33.7	75.5
EPS adjusted (₹)	19.4	21.1	21.1	19.6	18.3	25.4	38.7	37.9	3.5	33.7	75.5
	—	—	—	—	21.9%	19.7%	15.5%	15.8%	85%	26.7%	19.9%
Annual report	Annual report for Mar 2016	Annual report for Mar 2017	Annual report for Mar 2018	Annual report for Mar 2019	Annual report for Mar 2020	Annual report for Mar 2021	Annual report for Mar 2022	Annual report for Mar 2023	Annual report for Mar 2024	Annual report for Mar 2025	Annual report for Mar 2026

₹ Cr	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity capital	90	90	90	90	90	90	90	90	90	90	90
Reserves	586	870	1,045	1,194	—	1,524	1,822	2,142	2,147	2,410	3,046
Minority interest	0	0	0	0	—	0	0	0	0	0	1
	38	0	170	0	—	68	38	3	3	0	0
	340	689	921	919	403	1,089	1,663	2,116	1,797	2,224	2,643
Total equity & liabilities	1,054	1,650	2,226	2,203	494	2,771	3,614	4,351	4,038	4,725	5,780
	89	210	226	372	28	21	14	668	708	750	989
CWIP	1	1	—	—	—	—	—	0	0	0	0
Investments	100	61	22	212	—	—	—	32	159	294	361
	863	1,378	1,978	1,620	—	—	—	3,651	3,171	3,680	4,430
Total assets	1,054	1,650	2,226	2,203	494	2,771	3,614	4,351	4,038	4,725	5,780

Segment results

As reported in NSE results XBRL. Segment result is before tax and finance costs. ROCE uses that annual result divided by segment assets less liabilities.

Source XBRL ↗

Latest reported period · 31 Mar 2026 · ₹ crore

Segment	Revenue	Result	Assets	Liabilities	Capital employed	ROCE %
Agrochemicals	4,716.86	684.88	4,832.74	2,357.86	2,474.88	27.67
Non-Agrochemicals	550.73	143.78

Loading financials…

Ratios

Annual operating, return, leverage and working-capital ratios.

Consolidated Standalone

Consolidated figures

Ratio	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	—	30.7%	31.7%	30.2%	29.3%	25.9%	29.9%	35.9%
EBITDA margin %	—	14.1%	18.2%	19.1%	15.9%	8.9%	13.8%	20.4%
EBIT margin %	—	7.2%	11.1%	12.2%	9.8%	0.5%	7.4%	14.3%
PAT margin %	8.8%	8.2%	9.6%	9.8%	8.5%	1%	7.1%	12.9%
Working capital
Receivable days	148	—	—	—	165	173	165	166
Inventory days	—	—	—	—	145	155	117	121
Payable days	—	—	—	—	176	144	158	162
NWC days	—	—	—	—	134	184	124	125
Leverage
Current ratio	—	—	1.84	1.69	1.65	1.86	1.81	1.86
Debt to EBITDA	—	—	0.16	0.06	0	0.01	0	0
Debt to equity	0	—	0.04	0.02	0	0	0	0
Interest coverage	-38.4	97.3	112.7	211.1	96.5	20.9	180.3	487.1
Asset turnover	0.91	4.06	0.86	0.99	0.93	0.78	0.91	0.91
Return ratios
Return on assets %	8%	33.4%	8.3%	9.7%	7.9%	0.8%	6.4%	11.8%
Return on capital employed %	—	—	19.1%	26.2%	20.2%	3.1%	14.6%	28%
Return on equity %	13.7%	—	14.2%	18.3%	15.3%	1.4%	12.2%	21.7%

Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.

Loading ratios…

Shareholding

Quarterly ownership, named holders, insider transactions and disclosed deals.

Quarterly Annual

Every quarter filed · % of equity

Holder (%)	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	74.82%	74.82%	74.82%	74.82%	74.82%	74.82%	74.82%	74.82%	74.82%	74.82%	74.82%	74.82%
	2.01%	2.06%	2.14%	2.02%	2.52%	3.77%	4.69%	5.48%	5.26%	4.2%	4.6%	3.11%
	12.29%	12.42%	12.41%	12.87%	12.76%	10.07%	10.27%	9.38%	9.26%	9.95%	9.69%	9.18%
Government	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
	10.88%	10.7%	10.63%	10.29%	9.9%	11.34%	10.22%	10.32%	10.66%	11.03%	10.89%	12.89%
No. of shareholders	—	—	—	—	—	—	—	—	67,290	65,567	61,155	63,572

Promoter holding up 0 percentage points since Sep 2023.

6 deals · 24 Jan 2022 – 28 Jul 2025

Date	Client	Type	Venue	Side	Quantity	Price	Value
28 Jul 2025	GRAVITON RESEARCH CAPITAL LLP	Bulk	NSE	Sell	7,05,137	₹1,111.15	₹78.35 Cr
28 Jul 2025	GRAVITON RESEARCH CAPITAL LLP	Bulk	NSE	Buy	7,05,137	₹1,111.31	₹78.36 Cr
28 Jul 2025	HRTI PRIVATE LIMITED	Bulk	NSE	Buy	4,51,608	₹1,108.00	₹50.04 Cr
28 Jul 2025	HRTI PRIVATE LIMITED	Bulk	NSE	Sell	4,41,400	₹1,110.57	₹49.02 Cr
24 Jan 2022	XTX MARKETS LLP	Bulk	NSE	Buy	4,58,598	₹433.39	₹19.88 Cr
24 Jan 2022	XTX MARKETS LLP	Bulk	NSE	Sell	4,58,271	₹434.00	₹19.89 Cr

1–6 of 6

1 / 1

Bulk deals are a client trading over 0.5% of the equity in a session, aggregated across their trades; block deals are single negotiated trades in the exchange’s block window. Each is reported by the exchange it was crossed on, so NSE and BSE rows are separate trades rather than the same trade twice.

Mr. Ramprakash V. BubnaExecutive Director-Chairperson-MD
Mrs. Sharda R. BubnaExecutive Director
Mr. Ashish R. BubnaExecutive Director
Mr. Manish R. BubnaExecutive Director
Ms. Sonal DesaiNon-Executive - Independent Director
Mr. H. S. Upendra KamathNon-Executive - Independent Director
Mr. Vinod Kumar KathuriaNon-Executive - Independent Director
Mr. Shalin S. DivatiaNon-Executive - Independent Director
Mr. Shailesh Anant MehendaleChief Financial Officer
Jetkin N GudhkaCompany Secretary & Compliance Officer

Current officeholders as filed with BSE. A person holding two offices is listed once per office.

Loading shareholding…

F&O

Current futures and options contracts with compact option-chain pages.

Not in the F&O segment

Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.

Loading f&o…

Fund holders

Mutual-fund schemes that disclosed a holding in the company.

Portfolio month

Schemes holding

across 3 fund houses

Held by these funds

1.55%

of the company's equity

All mutual funds

8.88%

shareholding pattern, Jun 2026

Portfolios as of

August 2026

compared with July 2026

4 schemes · 3 fund houses

		Shares
Small Cap Fund	DSP Mutual Fund	13.34 L	102.34	0.47%	1.479%	-0
(Investment Manager for Motilal Oswal Mutual Fund)	Motilal Oswal Mutual Fund	59,254	4.54	0.18%	0.066%	-1,297
IB18-Groww Nifty Total Market Index Fund	Groww Mutual Fund	405	0.03	0.01%	0%	+2
(Investment Manager for Motilal Oswal Mutual Fund)	Motilal Oswal Mutual Fund	67	0.01	0.01%	0%	-0

Loading fund holders…

Documents

Annual reports, exchange filings, offer documents, ratings and earnings-call material.

Announcements

Annual reports

Credit ratings

Crisil Ratings has reaffirmed its ''Crisil A1+'' rating on the short-term bank facilities of Sharda Cropchem Limited (SCL).23 Feb 2026 from CRISIL

Investor Presentation and earnings call

Jul 2026TranscriptAI SummaryPPT REC
May 2026Transcript AI Summary PPT

Documents link to external sources (exchange filings, company investor pages).

Loading documents…

Events

Upcoming dates and the company’s corporate-action history.

21

Final dividend7 Aug 2026 · ex-date₹9
Interim dividend6 Feb 2026 · ex-date₹6
Final dividend7 Aug 2025 · ex-date₹6
Interim dividend6 Feb 2025 · ex-date₹3
Final dividend2 Aug 2024 · ex-date₹3
Final dividend1 Aug 2023 · ex-date₹3
Interim dividend7 Feb 2023 · ex-date₹3
Final dividend25 Jul 2022 · ex-date₹3
Interim dividend2 Feb 2022 · ex-date₹3
Final dividend20 Jul 2021 · ex-date₹3
Interim dividend9 Nov 2020 · ex-date₹2
Interim dividend5 Mar 2020 · ex-date₹2
Interim dividend31 Jan 2020 · ex-date₹2
Final dividend16 Aug 2019 · ex-date₹2
Interim dividend4 Feb 2019 · ex-date₹2
Final dividend20 Aug 2018 · ex-date₹2
Interim dividend6 Nov 2017 · ex-date₹2
Interim dividend30 Mar 2017 · ex-date₹2
Interim dividend17 Nov 2016 · ex-date₹2
Interim dividend21 Mar 2016 · ex-date₹3
Dividend dividend10 Sept 2015 · ex-date₹2.5

1

Board meeting to consider results29 Jul 2026

Loading events…

Announcements

Latest exchange announcements, filings and downloadable documents.

1 month 3 months 6 months 1 year All

21 announcementsExport CSV

29 Jul 2026, 2:24 pmCompany Update

Announcement under Regulation 30 (LODR)-Investor Presentation

Investor Presentation PDF

Loading announcements…

Ratio	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	—	30.7%	31.7%	30.2%	29.3%	25.9%	29.9%	35.9%
EBITDA margin %	—	14.1%	18.2%	19.1%	15.9%	8.9%	13.8%	20.4%
EBIT margin %	—	7.2%	11.1%	12.2%	9.8%	0.5%	7.4%	14.3%
PAT margin %	8.8%	8.2%	9.6%	9.8%	8.5%	1%	7.1%	12.9%
Working capital
Receivable days	148	—	—	—	165	173	165	166
Inventory days	—	—	—	—	145	155	117	121
Payable days	—	—	—	—	176	144	158	162
NWC days	—	—	—	—	134	184	124	125
Leverage
Current ratio	—	—	1.84	1.69	1.65	1.86	1.81	1.86
Debt to EBITDA	—	—	0.16	0.06	0	0.01	0	0
Debt to equity	0	—	0.04	0.02	0	0	0	0
Interest coverage	-38.4	97.3	112.7	211.1	96.5	20.9	180.3	487.1
Asset turnover	0.91	4.06	0.86	0.99	0.93	0.78	0.91	0.91
Return ratios
Return on assets %	8%	33.4%	8.3%	9.7%	7.9%	0.8%	6.4%	11.8%
Return on capital employed %	—	—	19.1%	26.2%	20.2%	3.1%	14.6%	28%
Return on equity %	13.7%	—	14.2%	18.3%	15.3%	1.4%	12.2%	21.7%

Date	Category	Subject	Filing
29 Jul 2026, 2:24 pm	Company Update Investor Presentation	Announcement under Regulation 30 (LODR)-Investor Presentation	PDF
29 Jul 2026, 2:21 pm	Result Financial Results	Unaudited Financial Results For The Quarter Ended 30Th June, 2026	PDF
29 Jul 2026, 2:10 pm	Board Meeting Outcome of Board Meeting	Board Meeting Outcome for Outcome Of Board Meeting To Consider And Approve Unaudited Financial Results (Standalone And Consolidated) For Quarter Ended 30Th June 2026	PDF
22 Jul 2026, 12:40 pm	Company Update Analyst / Investor Meet	Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation	PDF
21 Jul 2026, 4:28 pm	Board Meeting	Board Meeting Intimation for Adoption Of Unaudited Standalone & Consolidated Financial Results For The Quarter Ended 30Th June, 2026.	PDF
15 Jul 2026, 11:27 am	Company Update Newspaper Publication	Announcement under Regulation 30 (LODR)-Newspaper Publication	PDF
14 Jul 2026, 11:55 am	Others Business Responsibility and Sustainability Reporting (BRSR)	Business Responsibility and Sustainability Reporting (BRSR)	PDF
14 Jul 2026, 11:46 am	Others Reg. 34 (1) Annual Report	Reg. 34 (1) Annual Report.	PDF

₹ Cr	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	197	181	17	556	246	249	267	328	341	604	656
	-120	-104	-163	-360	-282	-284	-208	-145	-393	-510	-513
	-89	-38	132	-216	43	43	-91	-97	-37	-68	-118
Net cash flow	-6	40	-11	-10	8	8	-32	86	-89	26	24
Free cash flow	196	178	7	551	—	249	267	328	341	603	655
CFO / Operating profit %	72.4%	58.1%	4.8%	—	87.4%	56.9%	39.1%	51.1%	120.7%	101.4%	60.9%

Sharda Cropchem Limited

About

Key insights

Key risks

Growth drivers

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Segment results

Ratios

Shareholding

F&O

Not in the F&O segment

Fund holders

Documents

Announcements

Annual reports

Credit ratings

Investor Presentation and earnings call

Events

21

1

Announcements

21

1

Not in the F&O segment

Announcements

Annual reports

Credit ratings

Investor Presentation and earnings call

Segment results

Compounded sales growth

Compounded profit growth

Return on equity

Agrochemicals · revenue

Sharda Cropchem Limited

About

Key insights

Key risks

Growth drivers

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Profit & loss

Balance sheet

Segment results

Ratios

Ratio timeline

Shareholding

Quarterly record

Bulk & block deals

Board and management

F&O

Not in the F&O segment

Fund holders

Documents

Announcements

Annual reports

Credit ratings

Investor Presentation and earnings call

Events

Dividends21

Board meetings1

Announcements

Dividends21

Board meetings1

Ratio timeline

Quarterly record

Bulk & block deals

Board and management

Not in the F&O segment

Announcements

Annual reports

Credit ratings

Investor Presentation and earnings call

Profit & loss

Balance sheet

Segment results

Cash flow

Compounded returns

Compounded sales growth

Compounded profit growth

Return on equity

Agrochemicals · revenue

21

1

21

1